PROM | Author (year) | Structural validity | Internal consistency | Reliability | Measurement error | Hypothesis testing | Cross-cultural validity | Criterion validity | Responsiveness |
CCEQ financial advice domain | Harley29 2019 | – (no data) | + (Cronbach’s α=0.71–0.88) | NR | NR | + (r=0.35–0.39) | NR | NR | NR |
COST-v1 | De Souza12 2014; De Souza27 2017 | NR | + (Cronbach’s α=0.92) | + (ICC=0.80) | NR | + (r=0.20–0.42) | NR | NR | NR |
COST-v1, Australia version | Durber28 2021 | NR | + (Cronbach’s α=0.89) | + (ICC=0.80) | NR | + (r=-0.39–0.52) | NR | NR | NR |
COST-v1, Brazilian version | de Alcantara Nogueira32 2020 | - (RMSEA=1.20) | + (Cronbach’s α=0.83) | NR | NR | NR | – (p<0.01) | NR | NR |
COST-v1, India version | Dar25 2021 | – (EFA: χ2=60.82) | ? (Cronbach’s α=0.92) | NR | NR | NR | NR | NR | NR |
COST-v1 Simplified Chinese version | Yu39 2021 | – (CFI=0.86; SRMR=0.08) | + (Cronbach’s α=0.85–0.88) | + (ICC=0.85) | NR | + (r=-0.57–0.88) | NR | NR | ? (no clear hypothesis) |
COST-v2, Italian version | Ripamonti33 2020 | ? (CFI=1.00; RMSEA=0.04) | ? (Cronbach’s α=0.83) | + (ICC=0.79) | NR | + (r=-0.66–0.15) | NR | + (β=−0.55) | NR |
COST-v2, Persian version | Sharif34 2020 | + (CFI=0.97; RMSEA=0.07) | + (Cronbach’s α=0.89) | NR | NR | ? (no clear hypothesis) | NR | NR | NR |
COST-v2, Traditional Chinese version | Chan24 2021 | – (CFI=0.91; RMSEA=0.15) | + (Cronbach’s α=0.86) | + (ICC=0.71) | NR | + (r=-0.46–0.47) | NR | NR | NR |
CPILS employment/financial domain | Zhao41 2009 | – (EFA: no model data) | + (Cronbach’s α=0.78–0.97) | NR | NR | ? (no clear hypothesis) | NR | NR | NR |
FIT | Hueniken31 2020 | – (EFA: no model data) | + (Cronbach’s α=0.77) | + (ICC=0.70) | NR | + (r=0.26–0.61) | NR | NR | + (r=−0.25) |
IOC-CS financial problems domain | Zebrack40 2010 | – (EFA: no model data) | – (Cronbach’s α=0.70–0.86) | – (ICC ≥0.75) | NR | – (>75% were not significant) | NR | ? (no data) | NR |
PFB | Veenstra37 2014 | – (CFA: no model data) | + (Cronbach’s α=0.79) | NR | NR | NR | NR | NR | NR |
PROFFIT | Riva42 2021 | – (EFA: no model data) | + (Cronbach’s α=0.87) | + (ICC=0.80) | NR | NR | NR | NR | NR |
PRRS financial well-being domain | Shilling35 2018 | – (EFA: no model data) | + (Cronbach’s α=0.90) | + (ICC=0.86) | NR | + (r=-0.71–0.65) | NR | + (r=−0.65) | NR |
P-SAFE, French Version | Tremblay36 2020 | NR | NR | NR | NR | NR | ? (no data) | NR | NR |
QLACS financial problems domain | Avis23 2005 | – (CFA: no model data) | + (Cronbach’s α=0.72) | NR | NR | + (r=-0.57–0.60) | NR | – (r=−0.72) | NR |
SDI-16 money matters domain | Wright16 2011 | – (EFA: no model data) | + (Cronbach’s α=0.71–0.82) | NR | NR | NR | NR | NR | NR |
SDI-21 providing for the family domain | Wright38 2005 | – (EFA: no model data) | + (Cronbach’s α=0.50–0.86) | – (Weighted kappa=0.54–0.80) | NR | – (33% were not significant) | NR | ? (r=−0.72) | NR |
SFDQ | Dar25 2021 | + (CFI=0.98, TLI=0.97, RMSEA=0.045, SRMR=0.014) | + (Cronbach’s α=0.85–0.88) | NR | NR | NR | NR | NR | NR |
SWBS | Head14 2008 | – (CFA: no model data) | + (Cronbach’s α=0.92) | NR | NR | + (r=-0.57–0.60) | NR | + (r=-0.12–0.03) | NR |
CCEQ, Chronic Cancer Experiences Questionnaire; CFA, Confirmatory Factor Analysis; CFI, Comparative Fit Index; COST, Comprehensive Score for Financial Toxicity; CPILS, Cancer Problems in Living Scale; EFA, Exploratory Factor Analysis; FIT, Financial Index of Toxicity; ICC, Intraclass Correlation Coefficient; IOC-CS, Impact of Cancer-Childhood Survivors; NA, not applicable; NR, not report; PFB, Personal Financial Burden ; PROFFIT, Patient-Reported Outcome for Fighting Financial Toxicity; PROM, patient-reported outcome measures; PRRS, Patient Roles and Responsibilities Scale ; P-SAFE, Patient Self-Administered Financial Effects questionnaire; QLACS, Quality of Life in Adult Cancer Survivors; RMSEA, Root Mean Square Error of Approximation; SDI, Social Difficulties Inventory Cancer Care Outcomes; SFDQ, Subjective Financial Distress Questionnaire; SRMR, Standardized Root Mean Square Residual; SWBS, Socioeconomic Well-being Scale.